CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

Sep 17, 2020

|

NEW YORK – Cardea Bio said on Thursday that it has raised $7.5 million in the first close of a Series A2 financing round.

The round was led by a partnership of venture capital firms, including Tsingyuan Ventures, Lifespan Investments, and longtime Cardea investor Serra Ventures, as well as Agilent Technologies, Table Mountain Capital, Photon Fund, and Taihill Venture, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

P.1 Re-infection Concerns

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

Aiming for May

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

NIH Program to Address Structural Racism

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Menu

CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

To read the full story....

Breaking News

Quanterix Q4 Revenues Up 64 Percent

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

Molecular Health Inks Agreement for Precision Medicine Tools With Falco Biosystems

Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs

The Scan

P.1 Re-infection Concerns

Aiming for May

NIH Program to Address Structural Racism

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

What's Popular?

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Sponsorships